- 全部删除
- 您的购物车当前为空
B2 (Linazolamide intermediate B impurity 2) 促进亨廷顿病和帕金森病细胞模型中的包涵体形成。
B2 (Linazolamide intermediate B impurity 2) 促进亨廷顿病和帕金森病细胞模型中的包涵体形成。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 397 | In stock | |
2 mg | ¥ 552 | In stock | |
5 mg | ¥ 833 | In stock | |
10 mg | ¥ 1,180 | In stock | |
25 mg | ¥ 1,970 | In stock | |
50 mg | ¥ 2,890 | In stock | |
100 mg | ¥ 3,920 | In stock | |
200 mg | ¥ 5,390 | In stock |
产品描述 | B2 (Linazolamide intermediate B impurity 2) promotes inclusion formation in cellular models of Huntington's disease and Parkinson's disease |
别名 | 奥司他韦杂质B(2-叠氮杂合物), Linazolamide intermediate B impurity 2, CPNQ, 5-[4-(4-Chlorobenzoyl)-1-piperazinyl]-8-nitroquinoline |
分子量 | 396.83 |
分子式 | C20H17ClN4O3 |
CAS No. | 115687-05-3 |
Smiles | [O-][N+](=O)c1ccc(N2CCN(CC2)C(=O)c2ccc(Cl)cc2)c2cccnc12 |
密度 | 1.412 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||||||||||||
溶解度信息 | Ethanol: < 1 mg/mL (insoluble or slightly soluble) H2O: 2 mg/mL (5.04 mM), Sonication is recommended. DMSO: 50 mg/mL (126 mM), Sonication is recommended. ![]() | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容